LPTX
Leap Therapeutics Inc.
Company Overview
| Mkt Cap | $12.01M | Price | $0.45 |
| Volume | 916.98K | Change | -2.57% |
| P/E Ratio | -0.2 | Open | $0.45 |
| Revenue | -- | Prev Close | $0.46 |
| Net Income | $-67.6M | 52W Range | $0.22 - $3.92 |
| Div Yield | N/A | Target | $1.25 |
| Overall | 36 | Value | 60 |
| Quality | 31 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyLeap Therapeutics Inc. (LPTX) is a leading Healthcare company in the Biotechnology industry, currently trading at $0.45 with a market capitalization of $12.01 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows LPTX with a volume of 917K shares. The stock opened down 1.46% from yesterday's close of $0.46. Current analyst estimates project earnings of $-1.11 per share for this year, with next year targeting $-0.53.
LPTX demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for LPTX include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 179.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 05:32 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LPTX | $0.45 | -2.6% | 916.98K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |